Fresenius SE failed to meet a goal of deciding whether to revive a 3.1-billion-euro ($3.9 billion) offer for German hospital operator Rhoen-Klinikum AG this month as both sides blamed each other for stalling the deal.
Smith & Nephew Plc rose the most in almost eight months in London trading after four U.K. newspapers reported that traders were speculating the maker of artificial knees and hips may receive a takeover offer.
Smith & Nephew Plc , Europe’s largest maker of knee and hip replacements, said it’s not in talks that may lead to a takeover or merger after the Daily Telegraph reported the company was about to start informal negotiations with Biomet Inc.
AstraZeneca Plc’s $1.26 billion purchase of Ardea Biosciences Inc., its biggest acquisition in five years, may be the first in a series of deals for the company as it tries to counter looming generic competition.
Sanofi-Aventis SA ’s talks to buy Genzyme Corp. are progressing, the French drugmaker said as it forecast profit will drop as much as 10 percent because of generic competition and the loss of flu vaccine sales.
AstraZeneca Plc, the U.K.’s second- biggest drugmaker, fell the most in five months after saying profit this year will decline as the company prepares to face generic competition to top-selling medicines.